1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
MJardin Group, Inc.

MJardin Group, Inc.

MJARF
MJardin Group, Inc.US flagOther OTC
0.00
USD
- -
- -
90,140.00Market Cap
2011 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2017 Y
2018 Y
2018 Y
2019 Y
2020 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.01
0.11
- -
- -
3.2
- -
0.67
0.33
0.13
0.06
Basic EPS, GAAP
-0.02
- -
-0.01
-0.01
0.01
0.05
-0.01
-0.01
0.24
-0.02
-2
-3.27
-0.39
-0.58
Free Cash Flow per Basic Share
-0.01
- -
-0.01
-0.01
- -
0.04
-0.01
-0.01
0.25
-0.01
-1.08
-0.75
-0.19
-0.12
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.59
- -
-0.61
-0.61
-0.61
-0.55
-0.57
-0.58
- -
-0.6
3.88
-1.2
-1.35
-1.59
Tangible Book Value per Share
0.04
- -
0.02
0.02
0.02
0.08
0.06
0.05
1.22
0.03
-0.26
-0.87
-1.01
-1.3
Basic Weighted Avg Shares
6
- -
6
6
6
6
6
6
6
6
41
82
89
94
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
- -
- -
20
- -
28
27
11
6
Operating Margin (%)
-4,449.72
- -
-4,018.97
-6,908.74
21.67
50.59
-2,688.32
-3,836.7
7.99
-3,456.84
-135.18
-220.6
-127.75
-173.01
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
-81
-267
-35
-55
Effective Tax Rate (%)
- -
- -
- -
- -
- -
9.28
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-4,449.72
- -
-4,018.97
-6,908.74
59.6
45.89
-2,688.32
-3,836.7
7.48
-3,456.84
-295.96
-1,001.87
-304.65
-908
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
40
- -
-117
-28
-162
-14
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
22
- -
3
116
5
173
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
16
- -
187
-61
-90
-122
Return on Invested Capital (%)
- -
- -
- -
- -
- -
104.64
- -
- -
4.6
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
-8.91
- -
- -
5.6
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'21
Jun'21
Sep'21
ST Debt
165
7
7
LT Borrowings
3
164
171
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
90
89
90
Market Capitalization
9
5
2

Working Capital

FRC

•

in mil. unless spec.
Mar'21
Jun'21
Sep'21
Total Current Assets
23
18
20
Cash, Cash Equivalents & STI
1
1
1
Accounts Receivable, Net
1
1
1
Inventories
9
9
7
Total Current Liabilities
190
34
34
Payables & Accruals
25
26
27
ST Debt
165
7
7
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10,096.53%
20,153.23%
47.83%
Free Cash Flow
8,141.33%
16,118.43%
-72.42%
Net Income, GAAP
7,845.62%
15,653.12%
-86.97%
Sales/Revenue/Turnover
180,162.61%
358,184.95%
-57.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
11
6
6
1
27
2020
2
2
5
2
11
2021
1
1
1
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
-0.1
-0.08
-0.16
- -
-3.27
2020
-0.09
-0.14
0.08
- -
-0.39
2021
-0.03
-0.1
-0.22
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Ali Mahdavi
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
1 Toronto Street Toronto ON Canada M5C 2V6
IPO Date
Nov 16, 2018
Website
mjardin.com
Similar Companies
CanaFarma Hemp Products Corp. (CNFA.CN)
Leef Brands Inc. (LEEEF)
Gridiron BioNutrients, Inc. (GMVP)
Vext Science, Inc. (VEXTF)
Krebs Biochemicals & Industries Limited (KREBSBIO.NS)
SES Solar Inc. (SESI)
Business
MJardin Group, Inc. (MJARF) operates as a vertically integrated cannabis company that cultivates, harvests, processes, and sells premium cannabis products including dried cannabis, fresh cannabis, cannabis plants, seeds, and plant extracts for medical and recreational markets in Canada and the United States; the company also provides consulting services such as strategic capital and financing advisory, project management for cultivation facilities, licensure support, facility design and construction oversight, systems implementation, equipment leasing, operational ramp-up, and access to proprietary intellectual property for licensed cannabis operators. Founded in 2014 and headquartered in Toronto, Ontario, with additional offices in Denver, Colorado, MJardin owns, manages, or advises on a portfolio of over 30 cannabis operations across multiple provinces in Canada and select U.S. states, emphasizing data-driven cultivation methodologies, sustainable practices, and partnerships with Canadian First Nations communities. Recent developments include ongoing commitments to joint ventures like the prior Warman facility transaction with Peguis First Nation and a focus on supply chain resilience amid regulatory evolution in the cannabis sector.

Company News

APIChat

  • globenewswire.com

    MJardin Group, Inc. Announces Revised Timeline for SISP

  • globenewswire.com

    MJardin Announces Executive Team Changes

  • globenewswire.com

    Flint & Embers Enters Canada's Largest Recreational Cannabis Market, Recreational Product Line Now Available in Ontario

  • globenewswire.com

    MJardin Group, Inc. Provides a Special Committee Update

  • globenewswire.com

    MJardin Group, Inc. Announces two new Board Members

  • globenewswire.com

    MJardin Group Announces Final Settlement of Remaining Cheyenne Sale Proceeds from Harvest; and Provides Update on Timing of Release of 2020 Financials

  • globenewswire.com

    MJardin Announces change in Board of Directors